Author: Stephen Grand

Precision oncology is revolutionising the way we approach cancer treatment. Unlike traditional methods, which often treat cancers in a more generic way, precision oncology tailors treatments to the individual characteristics of each patient’s cancer. This personalised approach, based on the genetic, molecular, and environmental factors of the cancer, is gaining recognition as one of the…

The North America stem cell assay market is poised for significant growth, with its value having reached an estimated USD 7.1 billion in 2023. This surge in market size can be attributed to a combination of factors, including increased investment in stem cell research, a growing focus on regenerative medicine, and advancements in stem cell…